In vitro high affinity α‐synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Amyloid containing deposits are a defining neuropathological feature of a wide range of dementias and movement disorders. The positron emission tomography tracer PIB (Pittsburgh Compound‐B, 2‐[4′‐(methylamino)phenyl]‐6‐hydroxybenzothiazole) was developed to target senile plaques, an amyloid containing pathological hallmark of Alzheimer’s disease, formed from the amyloid‐β peptide. Despite the fact that PIB was developed from the pan‐amyloid staining dye thioflavin T, no detailed characterisation of its interaction with other amyloid structures has been reported. In this study, we demonstrate the presence of a high affinity binding site (Kd∼4 nM) for benzothiazole derivatives, including [3H]‐PIB, on α‐synuclein (AS) filaments generated in vitro, and further characterise this binding site through the use of radioligand displacement assays employing 4‐N‐methylamino‐4′‐hydroxystilbene (SB13) (Ki = 87 nM) and 2‐(1‐{6‐[(2‐fluoroethyl(methyl)amino]‐2‐naphthyl}ethylidene)malononitrile (FDDNP) (Ki = 210 nM). Despite the presence of a high‐affinity binding site on AS filaments, no discernible interaction of [3H]‐PIB was detected with amygdala sections from Parkinson’s disease cases containing frequent AS‐immunoreactive Lewy bodies and related neurities. These findings suggest that the density and/or accessibility of AS binding sites in vivo are significantly less than those associated with amyloid‐β peptide lesions. Lewy bodies pathology is therefore unlikely to contribute significantly to the retention of PIB in positron emission tomography imaging studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104 · cited 5×
“…detailed description of the interaction of imaging tracers with an amyloid pool other than fibrillar Ab and additionally, complements the developing literature surrounding the application of amyloid agents in non-AD dementia patient populations such as DLB (Bacskai et al. 2007; Rowe et al. 2007).”
BackgroundMethodInfluentialDifferences in neuropathologic characteristics across the Lewy body dementia spectrum
Ballard, C., Ziabreva, I., Perry, R., Larsen, J. P., O'Brien, J., McKeith, I., Perry, E., & Aarsland, D. (2006) · Neurology · doi:10.1212/01.wnl.0000249130.63615.cc · Cited by 335 · cited 1×
“A common neuropathological finding associated with both normal ageing and a range of dementias is the presence of senile plaques (SPs) formed from amyloid-beta (Ab) peptides (Braak and Braak 1991; Bouras et al. 1994; Tsuboi and Dickson 2005; Ballard et al. 2006).”
BackgroundPIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302 · cited 10×
“In addition, this study provides further specific support to the observation that in vivo PIB is likely to be a non-disease specific imaging marker of Ab peptide-related cerebral amyloidosis (Lockhart et al. 2007).”
MethodResultInfluentialSelf-citationBouras, C., Hof, P. R., Giannakopoulos, P., Michel, J.-P., & Morrison, J. H. (1994) · Cerebral Cortex · doi:10.1093/cercor/4.2.138 · Cited by 280
Lockhart, A., Ye, L., Judd, D. B., Merritt, A. T., Lowe, P. N., Morgenstern, J. L., Hong, G., Gee, A. D., & Brown, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412056200 · Cited by 213 · cited 11×
“Radioligand binding assay of a-synuclein Assays were performed as described (Lockhart et al. 2005) using a fixed concentration of AS (200 nM) and a range of [3H]-Me-BTA-1 or [3H]-PIB concentrations (40, 16, 6.4, 2.56, 1.026, 0.4096, 0.16384 and 0.065536 nM) with the following modifications.”
BackgroundMethodResultInfluentialSelf-citationLewy Body Pathology in Alzheimer's Disease
Kotzbauer, P. T., Tojanowski, J. Q., & Lee, V. M. V. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:225 · Cited by 177 · cited 3×
“In LBs, at least some AS filaments are extensively phosphorylated and nitrated, in addition to being ubiquitinated (Goedert 2001; Kotzbauer et al. 2001).”
Background
Cited by
Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases
Irvine, G. B., El-Agnaf, O. M., Shankar, G. M., & Walsh, D. M. (2008) · Molecular Medicine · doi:10.2119/2007-00100.irvine · Cited by 550
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
Beach, T. G., Adler, C. H., Sue, L. I., Serrano, G., Shill, H. A., Walker, D. G., Lue, L., Roher, A. E., Dugger, B. N., Maarouf, C., et al. (2015) · Neuropathology · doi:10.1111/neup.12189 · Cited by 460
Self-citationSensitivity and specificity of phospho‐Ser129 α‐synuclein monoclonal antibodies
Delic, V., Chandra, S., Abdelmotilib, H., Maltbie, T., Wang, S., Kem, D., Scott, H. J., Underwood, R. N., Liu, Z., Volpicelli‐Daley, L. A., et al. (2018) · Journal of Comparative Neurology · doi:10.1002/cne.24468 · Cited by 95
Axonopathy in Huntington's disease
Li, J.-Y., & Conforti, L. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.010 · Cited by 55
“In addition, mHTT inhibits differentiation and neurite outgrowth in PC12 cells (Song et al., 2002; Wyttenbach et al., 2001; Ye et al., 2008).”
Metadata
- Authors
- Ye, L., Velasco, A., Fraser, G., Beach, T. G., Sue, L., Osredkar, T., Libri, V., Spillantini, M. G., Goedert, M., & Lockhart, A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2008-01-21
- Volume
- 105
- Issue
- 4
- Pages
- 1428-1437
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2024718702
- Cited by
- 92
- References
- 7
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro high affinity α‐synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1. https://app.cochat.ai/papers/10.1111/j.1471-4159.2008.05245.x
- The paper
- Ye, L., Velasco, A., Fraser, G., Beach, T. G., Sue, L., Osredkar, T., Libri, V., Spillantini, M. G., Goedert, M., & Lockhart, A. (2008). In vitro high affinity α‐synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2008.05245.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.